LPC
REPL icon

Lion Point Capital’s Replimune Group REPL Stock Holding History

Lion Point Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,500
Closed -$347K – 29
2024
Q1 		$347K Hold
42,500
– – 0.19% 24
2023
Q4 		$358K Buy
42,500
+7,500
+21% +$87K 0.18% 23
2023
Q3 		$599K Buy
+35,000
New +$687K 0.27% 23

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lion Point Capital's REPL Position: Q2 2024 in Review

Lion Point Capital sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 42,500 shares — an estimated $347K sold.

Lion Point Capital first reported a position in REPL in Q3 2023 and held it in 3 quarters. The position peaked at $599K in Q3 2023. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Lion Point Capital reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Lion Point Capital sold 42,500 Replimune Group shares in Q2 2024, an estimated $347K.
  • Lion Point Capital first reported a position in Replimune Group in Q3 2023 and held it in 3 quarters.
  • Lion Point Capital's Replimune Group position peaked at $599K in Q3 2023.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Lion Point Capital's 13F filing for Q2 2024, filed 14 Aug 2024.